Publications by authors named "Yu Cheng Zhao"

Claim this Profile
R
Retraction Note: High-rate aluminium yolk-shell nanoparticle anode for Li-ion battery with long cycle life and ultrahigh capacity.
Sa Li, Junjie Niu, Yu Cheng Zhao, Kang Pyo So, Chao Wang

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L. Leaves - Integration of Their Transcriptome and Metabolomics Dataset: Investigating Potential Genes Involved in Flavonoid Biosynthesis at Different Harvest Times.
Ding-Qiao Xu, Shu-Yan Cheng, Jun-Qing Zhang, Han-Feng Lin, Yan-Yan Chen, Yu-Cheng Zhao

Front Plant Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Research Advances in Structural Characteristics,Identification Methods,and Functions of Telocytes].
Teng Li, Ying Xu, Qiu-Yan Jiang, Yu-Cheng Zhao, Zhi-Zheng Wu

Zhongguo Yi Xue Ke Xue Yuan Xue Bao· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of surgical resection for complicated liver cancer and its influencing factors: A retrospective study.
Jian Yu, Zhi-Zheng Wu, Teng Li, Ying Xu, Yu-Cheng Zhao

World J Clin Cases· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Distribution of Telocytes in Vital Organs of ApoE Mice].
Ying Xu, Hu Tian, Jian Yu, Jia Lin Cheng, Yu Cheng Zhao

Zhongguo Yi Xue Ke Xue Yuan Xue Bao· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: High-rate aluminium yolk-shell nanoparticle anode for Li-ion battery with long cycle life and ultrahigh capacity.
Sa Li, Junjie Niu, Yu Cheng Zhao, Kang Pyo So, Chao Wang

Nat Commun· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-rate aluminium yolk-shell nanoparticle anode for Li-ion battery with long cycle life and ultrahigh capacity.
Sa Li, Junjie Niu, Yu Cheng Zhao, Kang Pyo So, Chao Wang

Nat Commun· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).
Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Roberto Bolli, Zuo Chen, Yu-Cheng Zhao

Int J Cardiol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metal switch for controlling the activity of molecular motor proteins.
Jared C Cochran, Yu Cheng Zhao, Dean E Wilcox, F Jon Kull

Nat Struct Mol Biol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Zuo Chen, Yang-Feng Wu, Yu-Cheng Zhao

Clin Exp Hypertens· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the kinesin ATPase cycle by neck linker docking and microtubule binding.
Yu Cheng Zhao, F Jon Kull, Jared C Cochran

J Biol Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Zuo Chen, Yang-Feng Wu, Yu-Cheng Zhao

Ann Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
Jian-Jun Li, Zong-Liang Lu, Wen-Rong Kou, Zuo Chen, Yang-Feng Wu, Yu-Cheng Zhao

J Clin Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
Ping Ye, Zong-Liang Lu, Bao-min Du, Zuo Chen, Yang-Feng Wu, Yu-Cheng Zhao

J Am Geriatr Soc· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
Shui-ping Zhao, Zong-liang Lu, Bao-min Du, Zuo Chen, Yang-feng Wu, Yu-cheng Zhao

J Cardiovasc Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis